Scientists developed a new tool to provide a selection of drugs to a broader spectrum of cancer patients. This is a step towards personalised cancer treatment.
Today, cancer therapies are primarily aimed at tackling tumours with DNA abnormalities, which leaves 60 % of patients who cannot benefit from personalised treatment.
Further details: Personalised cancer treatment